Literature DB >> 32668122

Etiologic Index - A Case-Only Measure of BRCA1/2-Associated Cancer Risk.

Raymond Hughley1, Rosa Karlic2, Himanshu Joshi1, Clare Turnbull3, William D Foulkes4, Paz Polak1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32668122      PMCID： PMC7546370          DOI： 10.1056/NEJMc1913988

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   176.079


× No keyword cloud information.
  5 in total

1.  A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer.

Authors:  Paz Polak; Jaegil Kim; Lior Z Braunstein; Rosa Karlic; Nicholas J Haradhavala; Grace Tiao; Daniel Rosebrock; Dimitri Livitz; Kirsten Kübler; Kent W Mouw; Atanas Kamburov; Yosef E Maruvka; Ignaty Leshchiner; Eric S Lander; Todd R Golub; Aviad Zick; Alexandre Orthwein; Michael S Lawrence; Rajbir N Batra; Carlos Caldas; Daniel A Haber; Peter W Laird; Hui Shen; Leif W Ellisen; Alan D D'Andrea; Stephen J Chanock; William D Foulkes; Gad Getz
Journal:  Nat Genet       Date:  2017-08-21       Impact factor: 38.330

2.  Cancer risks in BRCA2 mutation carriers.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1999-08-04       Impact factor: 13.506

3.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

4.  Tumour lineage shapes BRCA-mediated phenotypes.

Authors:  Philip Jonsson; Chaitanya Bandlamudi; Michael L Cheng; Preethi Srinivasan; Shweta S Chavan; Noah D Friedman; Ezra Y Rosen; Allison L Richards; Nancy Bouvier; S Duygu Selcuklu; Craig M Bielski; Wassim Abida; Diana Mandelker; Ozge Birsoy; Liying Zhang; Ahmet Zehir; Mark T A Donoghue; José Baselga; Kenneth Offit; Howard I Scher; Eileen M O'Reilly; Zsofia K Stadler; Nikolaus Schultz; Nicholas D Socci; Agnes Viale; Marc Ladanyi; Mark E Robson; David M Hyman; Michael F Berger; David B Solit; Barry S Taylor
Journal:  Nature       Date:  2019-07-10       Impact factor: 49.962

5.  Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants.

Authors:  Kandamurugu Manickam; Adam H Buchanan; Marci L B Schwartz; Miranda L G Hallquist; Janet L Williams; Alanna Kulchak Rahm; Heather Rocha; Juliann M Savatt; Alyson E Evans; Loren M Butry; Amanda L Lazzeri; D'Andra M Lindbuchler; Carroll N Flansburg; Rosemary Leeming; Victor G Vogel; Matthew S Lebo; Heather M Mason-Suares; Derick C Hoskinson; Noura S Abul-Husn; Frederick E Dewey; John D Overton; Jeffrey G Reid; Aris Baras; Huntington F Willard; Cara Z McCormick; Sarath B Krishnamurthy; Dustin N Hartzel; Korey A Kost; Daniel R Lavage; Amy C Sturm; Lauren R Frisbie; T Nate Person; Raghu P Metpally; Monica A Giovanni; Lacy E Lowry; Joseph B Leader; Marylyn D Ritchie; David J Carey; Anne E Justice; H Lester Kirchner; W Andrew Faucett; Marc S Williams; David H Ledbetter; Michael F Murray
Journal:  JAMA Netw Open       Date:  2018-09-07
  5 in total
  4 in total

1.  Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer.

Authors:  Fadi Taza; Albert E Holler; Wei Fu; Hao Wang; Nabil Adra; Costantine Albany; Ryan Ashkar; Heather H Cheng; Alexandra O Sokolova; Neeraj Agarwal; Adam Kessel; Alan Bryce; Nellie Nafissi; Pedro Barata; A Oliver Sartor; Diogo Bastos; Oren Smaletz; Jacob E Berchuck; Mary-Ellen Taplin; Rahul Aggarwal; Cora N Sternberg; Panagiotis J Vlachostergios; Ajjai S Alva; Christopher Su; Catherine H Marshall; Emmanuel S Antonarakis
Journal:  JCO Precis Oncol       Date:  2021-07-22

2.  Li-Fraumeni Syndrome in the Cancer Genomics Era.

Authors:  William D Foulkes; Paz Polak
Journal:  J Natl Cancer Inst       Date:  2021-07-07       Impact factor: 11.816

3.  Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer.

Authors:  Tamara L Lotan; Harsimar B Kaur; Daniela C Salles; Sanjana Murali; Edward M Schaeffer; Jerry S Lanchbury; William B Isaacs; Robert Brown; Andrea L Richardson; Olivier Cussenot; Geraldine Cancel-Tassin; Kirsten M Timms; Emmanuel S Antonarakis
Journal:  Mod Pathol       Date:  2021-01-18       Impact factor: 8.209

Review 4.  Building towards Precision Oncology for Pancreatic Cancer: Real-World Challenges and Opportunities.

Authors:  Yifan Wang; Anna Lakoma; George Zogopoulos
Journal:  Genes (Basel)       Date:  2020-09-21       Impact factor: 4.096
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.